Visual impairment and medication safety: a protocol for a scoping review

Autor: Karen Davies, Lisa Riste, Caroline Sanders, Darren M. Ashcroft, Sudeh Cheraghi-Sohi, Christine Dickenson, Maria Panagioti, Sally J Giles, Isabel Adeyemi, Denham Phipps, Penny J. Lewis, Rebecca Morris
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Giles, S J, Panagioti, M, Riste, L, Cheraghi-Sohi, S, Lewis, P, Adeyemi, I, Davies, K, Morris, R, Phipps, D, Dickinson, C, Ashcroft, D & Sanders, C 2021, ' Visual impairment and medication safety: a protocol for a scoping review ', Systematic Reviews, vol. 10, no. 1, 248 . https://doi.org/10.1186/s13643-021-01800-8
Systematic Reviews
Systematic Reviews, Vol 10, Iss 1, Pp 1-6 (2021)
DOI: 10.1186/s13643-021-01800-8
Popis: Background The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people. Methods/design Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics. Discussion The review will summarise the literature relating to medication safety and visual impairment.
Databáze: OpenAIRE